Ampio Pharmaceuticals Inc. (AMPE) - Live Price

Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc. (AMPE) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for diseases that affect the musculoskeletal system. With a strong pipeline of potential blockbuster drugs, AMPE is gaining attention from investors and researchers alike. The company's lead product, Ampion, is a proprietary injectable drug candidate designed to reduce inflammation and pain while promoting healing in various musculoskeletal disorders, such as osteoarthritis and rheumatoid arthritis. AMPE's growth strategy involves advancing Ampion through clinical trials, partnering with major pharmaceutical companies, and exploring new indications for their other promising candidates, like Athenafi and Apligraf. As the company progresses in its development and regulatory efforts, investors may find AMPE a compelling opportunity to invest in a cutting-edge musculoskeletal disease treatment pioneer.

Get Ampio Pharmaceuticals Inc. Price Change Alerts

Verdasi can notify you when AMPE goes up or down. Get a text message or email when Ampio Pharmaceuticals Inc. changes in price.

How Many People are employed by Ampio Pharmaceuticals, Inc.?

How are Ampio Pharmaceuticals Inc. divided?

Approximately 2.69% of Ampio Pharmaceuticals Inc. are owned by individual stakeholders. Mutual Funds actively invest in Ampio Pharmaceuticals, Inc., controlling roughly 5.60% of all Ampio Pharmaceuticals Inc..

• Individual Stakeholders: 2.69%
• Mutual Fund: 5.60%
• Other Institutions: 0.00%

How much is Ampio Pharmaceuticals Inc. stock worth?

Ampio Pharmaceuticals Inc. (AMPE) is worth $0.21 USD as of November 21, 2024, 9:50 am UTC time.
View the interactive graph to see how much Ampio Pharmaceuticals Inc. has changed in the last hour or historically.